Package 21130-554-27

{"route": ["ORAL"], "spl_id": "46510bfe-1c72-5f4d-e063-6294a90aa930", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["f32e5b0f-1fd9-9b33-e053-2995a90a8103"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Safeway, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET in 1 BLISTER PACK (21130-554-27)", "package_ndc": "21130-554-27", "marketing_start_date": "20230630"}], "brand_name": "Guaifenesin", "product_id": "21130-554_46510bfe-1c72-5f4d-e063-6294a90aa930", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "21130-554", "generic_name": "Guaifenesin", "labeler_name": "Safeway, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA213420", "marketing_category": "ANDA", "marketing_start_date": "20230630", "listing_expiration_date": "20261231"}